These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32904568)
1. Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries. Yan F; Shi F; Li X; Yu C; Lin Y; Li Y; Jin M Cancer Manag Res; 2020; 12():7569-7578. PubMed ID: 32904568 [TBL] [Abstract][Full Text] [Related]
2. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry. Guo AT; Song X; Wei LX; Zhao P World J Gastroenterol; 2011 Aug; 17(30):3531-7. PubMed ID: 21941421 [TBL] [Abstract][Full Text] [Related]
3. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
4. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072 [TBL] [Abstract][Full Text] [Related]
5. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour. Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980 [TBL] [Abstract][Full Text] [Related]
6. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases. Schmoeckel E; Kirchner T; Mayr D Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003 [TBL] [Abstract][Full Text] [Related]
7. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Ronnett BM; Seidman JD Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249 [TBL] [Abstract][Full Text] [Related]
8. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
9. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935 [TBL] [Abstract][Full Text] [Related]
10. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Ronnett BM; Shmookler BM; Diener-West M; Sugarbaker PH; Kurman RJ Int J Gynecol Pathol; 1997 Jan; 16(1):1-9. PubMed ID: 8986525 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum]. Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014 [TBL] [Abstract][Full Text] [Related]
14. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201 [TBL] [Abstract][Full Text] [Related]
15. A case of Pseudomyxoma Peritonei of an unexpected origin. Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348 [TBL] [Abstract][Full Text] [Related]
16. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Young RH Semin Diagn Pathol; 2004 May; 21(2):134-50. PubMed ID: 15807473 [TBL] [Abstract][Full Text] [Related]
17. An unusual case of pseudomyxoma peritonei associated with synchronous primary mucinous tumors of the ovary and appendix: A case report. Suh DS; Song YJ; Kwon BS; Lee S; Lee NK; Choi KU; Kim KH Oncol Lett; 2017 Jun; 13(6):4813-4817. PubMed ID: 28599482 [TBL] [Abstract][Full Text] [Related]
18. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Prayson RA; Hart WR; Petras RE Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074 [TBL] [Abstract][Full Text] [Related]
19. Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma. Taguchi A; Rokutan H; Oda K; Tanikawa M; Tanimoto S; Sone K; Mori M; Tsuruga T; Kohsaka S; Tatsuno K; Shinozaki-Ushiku A; Miyagawa K; Mano H; Aburatani H; Ushiku T; Osuga Y BMC Med Genomics; 2022 Mar; 15(1):51. PubMed ID: 35255903 [TBL] [Abstract][Full Text] [Related]